首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1813332

分子诊断：技术与全球市场

Molecular Diagnostics: Technologies and Global Markets

出版日期: 2025年09月04日 | 出版商:

BCC Research | 英文 142 Pages | 订单完成后即时交付

价格

简介目录图表

全球分子诊断市场预计将从 2025 年的 230 亿美元成长到 2030 年底的 426 亿美元，在 2025-2030 年预测期内的年复合成长率为 13.1%。

预计北美分子诊断市场在预测期（2025-2030年）将以12.5%的复合年增长率成长，从2025年的96亿美元成长到2030年底的173亿美元。

预计欧洲分子诊断市场将从 2025 年的 63 亿美元成长到 2030 年底的 119 亿美元，预测期内（2025-2030 年）的复合年增长率为 13.6%。

调查范围

本报告对全球分子诊断市场进行了全面的研究，包括市场规模分析、製造商产品和策略的详细分析以及基于技术、产品/服务、应用和地区的细分。

本报告概述了全球分子诊断市场并分析了市场趋势。报告提供了基准年 2024 年的全球收益（百万美元），并对预测期从 2025 年到 2030 年底进行了估算。市场按产品/服务类型、应用、技术和地区进行细分。根据产品/服务类型，市场进一步细分为消耗品、仪器、软体和服务。根据技术，市场细分为聚合酵素链锁反应(PCR)、次世代定序(NGS)、原位杂合反应(ICH)、微阵列和其他。根据应用，市场细分为感染疾病、肿瘤学、产前和产后检测、身份和亲子鑑定和其他。

该报告还重点关注北美、欧洲、亚太地区和世界其他地区的市场区域细分，并重点关注这些地区的主要国家。报告重点介绍了影响市场和供应商格局的关键驱动趋势和挑战。报告分析了环境、社会和治理(ESG) 发展情况，并讨论了与市场相关的专利和新兴技术。

报告最后对竞争格局和行业结构进行了分析，还包括一个专门的公司简介部分，详细介绍了主要企业。

报告内容

95 个资料表和 54 个附加表
全球分子诊断市场概况与分析
全球市场趋势分析，包括 2022 年至 2024 年的历史收益数据、2025 年的估计和预测以及 2030 年的复合年增长率预测
按产品/服务类型、技术、应用和地区进行市场份额分析，以及全球市场规模和收益预测的估计
有关市场动态、机会和阻碍因素、技术进步、法规和宏观经济变数影响的事实和数据
波特五力模型与全球供应链分析的见解
评估现有产品、进行临床试验并确定新产品和检测方法开发的新潜在市场
专利分析重点突出已授权和已公布的关键专利
概述产业永续性趋势和 ESG 发展，重点在于主要企业实施的 ESG 实践、ESG评级和消费者意识
产业结构分析，包括企业市场占有率和排名、策略联盟、併购和创业融资前景
主要企业简介包括 F. Hoffmann-La Roche Ltd.、Danaher Corp.、Biomerieux、Exact Sciences Corp. 和 Hologic Inc.

细分市场
依技术进行市场分析
关键要点
聚合酵素链锁反应（PCR）
次世代定序（NGS）
原位杂交
微阵列
其他的
按产品/服务进行市场分析
关键要点
耗材
装置
软体和服务
按应用进行市场分析
关键要点
感染疾病
肿瘤学
产前和产后筛检
身份识别和亲子鑑定
其他的
地理分布
区域市场分析
关键要点
北美洲
欧洲
亚太地区
其他地区

第六章竞争讯息

关键要点
产业结构
分子诊断市场企业市场占有率分析
战略分析

第七章分子诊断市场的永续性：ESG 视角

第八章附录

调查方法
来源
简称
公司简介
ABBOTT
AGILENT TECHNOLOGIES INC.
BD
BIOMERIEUX
BIO-RAD LABORATORIES INC.
DANAHER CORP.
EXACT SCIENCES CORP.
F. HOFFMANN-LA ROCHE LTD.
HOLOGIC INC.
ILLUMINA INC.
MYRIAD GENETICS INC.
QIAGEN
REVVITY
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
新兴Start-Ups/市场颠覆者

简介目录图表

Product Code: BIO063F

The global market for molecular diagnostics is expected to grow from $23 billion in 2025 and is projected to reach $42.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2025 to 2030.

The North American market for molecular diagnostics is expected to grow from $9.6 billion in 2025 and is projected to reach $17.3 billion by the end of 2030, at a CAGR of 12.5% during the forecast period of 2025 to 2030.

The European market for molecular diagnostics is expected to grow from $6.3 billion in 2025 and is projected to reach $11.9 billion by the end of 2030, at a CAGR of 13.6% during the forecast period of 2025 to 2030.

Report Scope

The scope of the global molecular diagnostics market study includes market size analysis and a detailed analysis of manufacturer products and strategies. The market has been segmented based on technology, product and service, application, and region.

This report provides an overview of the global market for molecular diagnostics and analyzes market trends. It includes global revenue ($ million) for the base year 2024 and estimated data for the forecast period 2025 through the end of 2030. The market is segmented based on product and service type, application, technology, and region. Further segmentation into consumables, instruments, software, and services is based on product and service type. Based on technology, the market is segmented into polymerase chain reaction (PCR), next-generation sequencing (NGS), in situ hybridization (ICH), microarrays, and others. Segmentation based on application includes infectious diseases, oncology, pre-and post-natal testing, identity/paternity testing, and others.

The report also focuses on regional segmentation of the market. The regions covered in this study include North America, Europe, Asia-Pacific, and the Rest of the World (RoW), focusing on major countries in these regions. The report focuses on the major driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social, and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape and industry structure. It also includes a dedicated section of company profiles with details about leading manufacturers.

Report Includes

95 data tables and 54 additional tables
An overview and analysis of the global markets for molecular diagnostics technologies
Analyses of the global market trends, with historic revenue data from 2022 to 2024, estimates for 2025, and projections of CAGRs through 2030
Estimates of the size and revenue prospects for the global market, along with a market share analysis by product and service type, technology, application and region
Facts and figures pertaining to market dynamics, opportunities and deterrents, technological advances, regulations and the impacts of macroeconomic variables
Insights derived from Porter's Five Forces model and global supply chain analyses
An assessment of current products, clinical trials and identification of new potential markets for novel products and assay development
Patent analysis, featuring key granted and published patents
Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings and consumer attitudes
Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Profiles of the leading companies, including F. Hoffmann-La Roche Ltd., Danaher Corp., Biomerieux, Exact Sciences Corp., and Hologic Inc.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion

Chapter 2 Market Overview

Overview
Clinical Applications of Molecular Diagnostics
Porter's Five Forces Analysis in the Market for Molecular Diagnostics
Potential for New Entrants (Moderate)
Bargaining Power of Suppliers (Low to Moderate)
Bargaining Power of Buyers (High)
Threat of Substitute Products (Low)
Industry Rivalry (High)
Macroeconomic Factor Analysis
U.S. Tariffs
Increasing Healthcare Expenditures

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Increasing Prevalence of Infectious Diseases
Growing Need for Early Detection of Chronic Diseases
Market Restraints
Regulatory Barriers
High Equipment and Testing Costs
Market Opportunities
Point-of-Care Testing
Companion Diagnostics for Targeted Therapies

Chapter 4 Emerging Technologies

Key Takeaways
Emerging Technologies
CRISPR-Based Diagnostics
Microfluidic POC Systems
Microbiome Analysis
Liquid Biopsy

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown
Market Analysis by Technology
Key Takeaways
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
In Situ Hybridization
Microarrays
Others
Market Analysis by Product and Service
Key Takeaways
Consumables
Instruments
Software and Services
Market Analysis by Application
Key Takeaways
Infectious Diseases
Oncology
Pre- and Post-Natal Screening
Identity and Paternity
Others
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence

Key Takeaways
Industry Structure
Company Share Analysis of the Molecular Diagnostics Market
Strategic Analysis

Chapter 7 Sustainability in the Molecular Diagnostics Market: An ESG Perspective

Introduction to ESG
ESG Practices in the Molecular Diagnostics Industry
Environmental Performance
Social Performance
Governance Performance
ESG Risk Ratings
Conclusion

Chapter 8 Appendix

Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
AGILENT TECHNOLOGIES INC.
BD
BIOMERIEUX
BIO-RAD LABORATORIES INC.
DANAHER CORP.
EXACT SCIENCES CORP.
F. HOFFMANN-LA ROCHE LTD.
HOLOGIC INC.
ILLUMINA INC.
MYRIAD GENETICS INC.
QIAGEN
REVVITY
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
Emerging Start-ups/ Market Disruptors

简介目录图表

List of Tables

Summary Table : Global Molecular Diagnostics Market, by Region, Through 2030
Table 1 : Comparison of Different Molecular Diagnostic Techniques
Table 2 : Global Molecular Diagnostics Market, by Technology, Through 2030
Table 3 : Global PCR Diagnostics Market, by Region, Through 2030
Table 4 : Global NGS Market, by Region, Through 2030
Table 5 : Global ISH Diagnostics Market, by Region, Through 2030
Table 6 : Global Microarray Diagnostics Market, by Region, Through 2030
Table 7 : Global Other Technologies Market, by Region, Through 2030
Table 8 : Global Molecular Diagnostics Market, by Product and Service, Through 2030
Table 9 : Global Molecular Diagnostic Consumables Market, by Region, Through 2030
Table 10 : Global Molecular Diagnostics Instruments Market, by Region, Through 2030
Table 11 : Global Molecular Diagnostics Software and Services Market, by Region, Through 2030
Table 12 : Global Molecular Diagnostics Market, by Application, Through 2030
Table 13 : Global Molecular Diagnostics Market for Infectious Diseases, by Region, Through 2030
Table 14 : Global Molecular Diagnostics Market for Oncology, by Region, Through 2030
Table 15 : Common Birth Defects and Their Frequency in the U.S.
Table 16 : Global Molecular Diagnostics Market for Pre- and Post-Natal Screening, by Region, Through 2030
Table 17 : Global Molecular Diagnostics Market for Identity and Paternity, by Region, Through 2030
Table 18 : Global Molecular Diagnostics Market for Other Applications, by Region, Through 2030
Table 19 : Global Molecular Diagnostics Market, by Region, Through 2030
Table 20 : North American Molecular Diagnostics Market, by Country, Through 2030
Table 21 : North American Molecular Diagnostics Market, by Technology, Through 2030
Table 22 : North American Molecular Diagnostics Market, by Product and Service, Through 2030
Table 23 : North American Molecular Diagnostics Market, by Application, Through 2030
Table 24 : U.S. Molecular Diagnostics Market, by Technology, Through 2030
Table 25 : U.S. Molecular Diagnostics Market, by Product and Service, Through 2030
Table 26 : U.S. Molecular Diagnostics Market, by Application, Through 2030
Table 27 : Canadian Molecular Diagnostics Market, by Technology, Through 2030
Table 28 : Canadian Molecular Diagnostics Market, by Product and Service, Through 2030
Table 29 : Canadian Molecular Diagnostics Market, by Application, Through 2030
Table 30 : Mexican Molecular Diagnostics Market, by Technology, Through 2030
Table 31 : Mexican Molecular Diagnostics Market, by Product and Service, Through 2030
Table 32 : Mexican Molecular Diagnostics Market, by Application, Through 2030
Table 33 : European Molecular Diagnostics Therapeutics Market, by Country, Through 2030
Table 34 : European Molecular Diagnostics Market, by Technology, Through 2030
Table 35 : European Molecular Diagnostics Market, by Product and Service, Through 2030
Table 36 : European Molecular Diagnostics Market, by Application, Through 2030
Table 37 : German Molecular Diagnostics Market, by Technology, Through 2030
Table 38 : German Molecular Diagnostics Market, by Product and Service, Through 2030
Table 39 : German Molecular Diagnostics Market, by Application, Through 2030
Table 40 : U.K. Molecular Diagnostics Market, by Technology, Through 2030
Table 41 : U.K. Molecular Diagnostics Market, by Product and Service, Through 2030
Table 42 : U.K. Molecular Diagnostics Market, by Application, Through 2030
Table 43 : French Molecular Diagnostics Market, by Technology, Through 2030
Table 44 : French Molecular Diagnostics Market, by Product and Service, Through 2030
Table 45 : French Molecular Diagnostics Market, by Application, Through 2030
Table 46 : Italian Molecular Diagnostics Market, by Technology, Through 2030
Table 47 : Italian Molecular Diagnostics Market, by Product and Service, Through 2030
Table 48 : Italian Molecular Diagnostics Market, by Application, Through 2030
Table 49 : Spanish Molecular Diagnostics Market, by Technology, Through 2030
Table 50 : Spanish Molecular Diagnostics Market, by Product and Service, Through 2030
Table 51 : Spanish Molecular Diagnostics Market, by Application, Through 2030
Table 52 : Rest of Europe Molecular Diagnostics Market, by Technology, Through 2030
Table 53 : Rest of Europe Molecular Diagnostics Market, by Product and Service, Through 2030
Table 54 : Rest of Europe Molecular Diagnostics Market, by Application, Through 2030
Table 55 : Asia-Pacific Molecular Diagnostics Market, by Country, Through 2030
Table 56 : Asia-Pacific Molecular Diagnostics Market, by Technology, Through 2030
Table 57 : Asia-Pacific Molecular Diagnostics Market, by Product and Service, Through 2030
Table 58 : Asia-Pacific Molecular Diagnostics Market, by Application, Through 2030
Table 59 : Chinese Molecular Diagnostics Market, by Technology, Through 2030
Table 60 : Chinese Molecular Diagnostics Market, by Product and Service, Through 2030
Table 61 : Chinese Molecular Diagnostics Market, by Application, Through 2030
Table 62 : Indian Molecular Diagnostics Market, by Technology, Through 2030
Table 63 : Indian Molecular Diagnostics Market, by Product and Service, Through 2030
Table 64 : Indian Molecular Diagnostics Market, by Application, Through 2030
Table 65 : Japanese Molecular Diagnostics Market, by Technology, Through 2030
Table 66 : Japanese Molecular Diagnostics Market, by Product and Service, Through 2030
Table 67 : Japanese Molecular Diagnostics Market, by Application, Through 2030
Table 68 : South Korean Molecular Diagnostics Market, by Technology, Through 2030
Table 69 : South Korean Molecular Diagnostics Market, by Product and Service, Through 2030
Table 70 : South Korean Molecular Diagnostics Market, by Application, Through 2030
Table 71 : Australian Molecular Diagnostics Market, by Technology, Through 2030
Table 72 : Australian Molecular Diagnostics Market, by Product and Service, Through 2030
Table 73 : Australian Molecular Diagnostics Market, by Application, Through 2030
Table 74 : Rest of Asia-Pacific Molecular Diagnostics Market, by Technology, Through 2030
Table 75 : Rest of Asia-Pacific Molecular Diagnostics Market, by Product and Service, Through 2030
Table 76 : Rest of Asia-Pacific Molecular Diagnostics Market, by Application, Through 2030
Table 77 : RoW Molecular Diagnostics Market, by Sub-Region, Through 2030
Table 78 : RoW Molecular Diagnostics Market, by Technology, Through 2030
Table 79 : RoW Molecular Diagnostics Market, by Product and Service, Through 2030
Table 80 : RoW Molecular Diagnostics Market, by Application, Through 2030
Table 81 : Recent Developments in the Molecular Diagnostics Market, 2022-2025
Table 82 : Environmental Performance Initiatives in the Molecular Diagnostics Market
Table 83 : Social Performance Initiatives in the Molecular Diagnostics Market
Table 84 : Governance Performance Initiatives in the Molecular Diagnostics Market
Table 85 : ESG Risk Rankings for Molecular Diagnostics Companies, 2025
Table 86 : Report Information Sources
Table 87 : Abbreviations Used in the Global Molecular Diagnostics Market
Table 88 : Abbott: Company Snapshot
Table 89 : Abbott: Financial Performance, FY 2023 and 2024
Table 90 : Abbott: Product Portfolio
Table 91 : Abbott: News/Key Developments, 2024
Table 92 : Agilent Technologies Inc.: Company Snapshot
Table 93 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
Table 94 : Agilent Technologies Inc.: Product Portfolio
Table 95 : Agilent Technologies Inc.: News/Key Developments, 2024-2025
Table 96 : BD: Company Snapshot
Table 97 : BD: Financial Performance, FY 2023 and 2024
Table 98 : BD: Product Portfolio
Table 99 : BD: News/Key Developments, 2025
Table 100 : bioMerieux: Company Snapshot
Table 101 : bioMerieux: Financial Performance, FY 2023 and 2024
Table 102 : bioMerieux: Product Portfolio
Table 103 : bioMerieux: News/Key Developments, 2024
Table 104 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 105 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
Table 106 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 107 : Bio-Rad Laboratories Inc.: News/Key Developments, 2025
Table 108 : Danaher Corp.: Company Snapshot
Table 109 : Danaher Corp.: Financial Performance, FY 2023 and 2024
Table 110 : Danaher Corp.: Product Portfolio
Table 111 : Danaher Corp.: News/Key Developments, 2025
Table 112 : Exact Sciences Corp.: Company Snapshot
Table 113 : Exact Sciences Corp.: Financial Performance, FY 2023 and 2024
Table 114 : Exact Sciences Corp.: Product Portfolio
Table 115 : Exact Sciences Corp.: News/Key Developments, 2022
Table 116 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 117 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 118 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 119 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2024
Table 120 : Hologic Inc.: Company Snapshot
Table 121 : Hologic Inc.: Financial Performance, FY 2023 and 2024
Table 122 : Hologic Inc.: Product Portfolio
Table 123 : Hologic Inc.: News/Key Developments, 2025
Table 124 : Illumina Inc.: Company Snapshot
Table 125 : Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 126 : Illumina Inc.: Product Portfolio
Table 127 : Illumina Inc.: News/Key Developments, 2025
Table 128 : Myriad Genetics Inc.: Company Snapshot
Table 129 : Myriad Genetics Inc.: Financial Performance, FY 2023 and 2024
Table 130 : Myriad Genetics Inc.: Product Portfolio
Table 131 : Myriad Genetics Inc.: News/Key Developments, 2024-2025
Table 132 : Qiagen: Company Snapshot
Table 133 : Qiagen: Financial Performance, FY 2023 and 2024
Table 134 : Qiagen: Product Portfolio
Table 135 : Qiagen: News/Key Developments, 2025
Table 136 : Revvity: Company Snapshot
Table 137 : Revvity: Financial Performance, FY 2023 and 2024
Table 138 : Revvity: Product Portfolio
Table 139 : Revvity: News/Key Developments, 2024-2025
Table 140 : Siemens Healthineers AG: Company Snapshot
Table 141 : Siemens Healthineers AG: Financial Performance, FY 2023 and 2024
Table 142 : Siemens Healthineers AG: Product Portfolio
Table 143 : Siemens Healthineers AG: News/Key Developments, 2024
Table 144 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 145 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 146 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 147 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023-2024
Table 148 : List of Few Emerging Startups

List of Figures

Summary Figure : Global Molecular Diagnostics Market Shares, by Region, 2024
Figure 1 : Porter's Five Forces Analysis of the Molecular Diagnostics Industry
Figure 2 : Market Dynamics of Global Molecular Diagnostics
Figure 3 : Emerging Technologies in the Molecular Diagnostics Market
Figure 4 : Global Molecular Diagnostics Market Shares, by Technology, 2024
Figure 5 : Global Molecular Diagnostics Market Shares, by Product and Service, 2024
Figure 6 : Global Molecular Diagnostics Market Shares, by Application, 2024
Figure 7 : Global Molecular Diagnostics Market Shares, by Region, 2024
Figure 8 : North American Molecular Diagnostics Market Shares, by Country, 2024
Figure 9 : European Molecular Diagnostics Market Shares, by Country, 2024
Figure 10 : Asia-Pacific Molecular Diagnostics Market Shares, by Country, 2024
Figure 11 : RoW Molecular Diagnostics Market Shares, by Sub-Region, 2024
Figure 12 : Company Market Shares in Molecular Diagnostics, 2024
Figure 13 : Key ESG Metrics of Molecular Diagnostics Companies
Figure 14 : Abbott: Revenue Shares, by Business Unit, FY 2024
Figure 15 : Abbott: Revenue Shares, by Country/Region, FY 2024
Figure 16 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 17 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 18 : BD: Revenue Shares, by Business Unit, FY 2024
Figure 19 : BD: Revenue Shares, by Country/Region, FY 2024
Figure 20 : bioMerieux: Revenue Shares, by Business Unit, FY 2024
Figure 21 : bioMerieux: Revenue Shares, by Country/Region, FY 2024
Figure 22 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 23 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 24 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 25 : Danaher Corp.: Revenue Shares, by Region, FY 2024
Figure 26 : Exact Sciences Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 27 : Exact Sciences Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 28 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2024
Figure 29 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2024
Figure 30 : Hologic Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 31 : Hologic Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 32 : Illumina Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 33 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 34 : Myriad Genetics Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 35 : Myriad Genetics Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 36 : Qiagen: Revenue Shares, by Business Unit, FY 2024
Figure 37 : Qiagen: Revenue Shares, by Country/Region, FY 2024
Figure 38 : Revvity: Revenue Shares, by Business Unit, FY 2024
Figure 39 : Revvity: Revenue Shares, by Country/Region, FY 2024
Figure 40 : Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2024
Figure 41 : Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2024
Figure 42 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 43 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024

02-2729-4219

+886-2-2729-4219

License/价格

分子诊断：技术与全球市场

Molecular Diagnostics: Technologies and Global Markets

调查范围

报告内容